ABSTRACT: A total of 150 weanling pigs [(Yorkshire × Landrace) × Duroc] with an average BW of 7.22 ± 0.80 kg (21 d of age) were used in a 28-d trial to determine the effects of dietary fructan and mannan oligosaccharides on growth performance, nutrient digestibility, blood profile, and diarrhea score in weanling pigs. Pigs were allotted randomly to 1 of 5 dietary treatments: 1) negative control (NC), basal diet; 2) positive control (PC), NC + 0.01% apramycin (165 mg/ kg); 3) NC + 0.1% fructan (FC); 4) NC + 0.1% mannan oligosaccharide source (MO); and 5) NC + 0.05% fructan + 0.05% mannan oligosaccharide source (FM). There were 3 replications per treatment with 10 pigs per pen (5 barrows and 5 gilts). From d 0 to 14, ADG and ADFI of pigs fed the PC, MO, and FM diets were greater (P < 0.05) than pigs fed the NC diet. From d 15 to 28, there were no differences (P > 0.05) in ADG, ADFI, and G:F. During the overall period (d 0 to 28), pigs fed the MO diet had a greater ADG than pigs fed the NC diet (P < 0.05). Pigs fed the PC and MO diets increased ADFI (P < 0.05) compared with pigs fed the NC diet. However, no differences were detected among dietary treatments in G:F during the overall experimental period. On d 14, the apparent total tract digestibility (ATTD) of DM and N in pigs fed the PC, MO, and FM diets was greater (P < 0.05) than pigs fed the NC diet. The ATTD of DM increased (P < 0.05) in pigs fed the MO and FM diets compared with pigs fed the FC diet. However, at the end of the experiment, pigs fed the FM diet had a greater (P < 0.05) ATTD of DM compared with pigs fed the NC diet. Additionally, there were no differences in IgG, red blood cells, white blood cells, and lymphocyte counts among dietary treatments on d 0, 14, or 28. The diarrhea score in pigs fed the MO diet was reduced (P < 0.05) compared with pigs fed the NC diet. In conclusion, mannan oligosaccharides have a beneficial effect on growth performance and nutrient digestibility in weanling pigs. Furthermore, mannan oligosaccharides can decrease diarrhea score in weanling pigs.
INTRODUCTION
Prebiotics first identified and named by Gibson and Roberfroid (1995) are nondigestible food ingredients, which stimulate the growth or activity or both of bacteria in the digestive system. In swine nutrition, probiotics, prebiotics, and synbiotics seem to be functional components with beneficial effects on growth performance, gastrointestinal function, and health. White et al. (2002) and LeMieux et al. (2003) reported that fructo-oligosaccharides, galacto-oligosaccharides, and mannan oligosaccharides have been used as prebiotics in livestock feed.
Mannan oligosaccharides consist of a mannan and a glucan component. The structure of the mannan component resembles that of the carbohydrates on the gut wall. In theory, pathogenic, growth-inhibiting microbes that normally adhere to mannans in the gut wall may bind instead to the mannan component of mannan oligosaccharides (Newman, 1994) . Previous data indicated that mannan oligosaccharides may improve growth performance in young pigs (Davis et al., 1999; Pettigrew, 2000) . However, White et al. (2002) reported that brewers dried yeast as a source of mannan oligosaccharides had no effect on nursery pig performance. Because of these different results, the efficacy of mannan oligosaccharides in pigs requires more detailed study.
Fructan is a fructose polymer consisting of a backbone of β-(2,6)-linked fructose, with 12% branching, which is produced by a variety of microorganisms (Han, 1990 ). Fructan has a wide variety of applications and can be used in medicine as a hypocholesterolemic agent (Yamamoto et al., 1999) , immune modulator (Yoo et al., 2004) , and anti-inflammatory agent (Vigants et al., 2001) . However, to the best of our knowledge, no studies have thus far been conducted to evaluate the use of fructan in swine. The principal objective of this study was to evaluate the effects of mannan oligosaccharides and fructan on growth performance, nutrient digestibility, blood immune variables, and diarrhea score in weanling pigs.
MATERIALS AND METHODS
The experimental protocol used in this study was approved by the Animal Care and Use Committee of Dankook University.
A source of fructan that consists of β-(2,6) linked fructose units was obtained from a commercial company (RealBioTech Co., Daejeon, South Korea). The product is synthesized via enzyme reactions using levansucrase from Zymomonas mobilis and purified using the ultra-membrane system. This source of fructan is different from inulin, which consists of β-(2,1) linked fructose units, and its partial hydrolysate, fructo-oligosaccharides. The average degree of polymerization is 10, and the average molecular weight is 700 kDa. The source of mannan oligosaccharides (BM; Bio-Mos, Alltech, Nicholasville, KY) contained 280.8 g of mannan, 250.5 g of mannose, and 450.6 g of dextrin/kg on a DM basis. Those fractions were separated using HPLC.
Experimental Design, Animals, and Housing
A total of 150 weanling pigs [(Yorkshire × Landrace) × Duroc] with an average BW of 7.22 ± 0.80 kg (21 d of age) were used in a 28-d experiment. Pigs were randomly allotted to 5 experimental diets (Tables 1 and  2 ) according to their initial BW and sex (3 replications; 5 gilts and 5 barrows/pen). Dietary treatment groups were 1) negative control (NC), basal diet; 2) positive control (PC), NC + 0.01% apramycin (165 mg/kg); 3) NC + 0.1% fructan (FC); 4) NC + 0.1% BM (MO); and 5) NC + 0.05% fructan + 0.05% BM (FM). The diets were formulated to meet or exceed the NRC (1998) nutrient requirements. Treatment additives were included in the diet by replacing the same amount of corn. All the pigs were housed in an environmentally controlled room with a slatted plastic floor. Each pen was equipped with a 1-sided self-feeder and a nipple waterer to allow the pig ad libitum access to feed and water throughout the experimental period. Temperature during wk 1 was maintained at 32°C and was reduced 2.5°C each week thereafter.
Sampling and Measurements
Individual pig BW was recorded at the beginning, middle (d 14) , and end (d 28) of the experimental period, and feed consumption was recorded on a pen basis during the experiment to calculate ADG, ADFI, and G:F. From d 8 to 14 and from d 22 to 28, pigs were fed diets mixed with chromic oxide (0.2%) as an indigestible marker for the determination of apparent total tract digestibility (ATTD) for DM and N (Fenton and Fenton, 1979) . On d 14 and 28, fecal samples were collected from at least 2 pigs in each pen via rectal mas- Dietary treatments were negative control diet = basal diet as indicated; positive control diet = basal diet with 0.01% apramycin during phase 1 and phase 2; fructan diet = basal diet with 0.1% fructan (RealBioTech Co., Daejeon, South Korea); mannan oligosaccharide diet = basal diet with 0.1% of the source of mannan oligosacchartides [BioMos (BM), Alltech, Nicholasville, KY]; fructan and mannan oligosaccharide diet = basal diet with 0.05% fructan and 0.05% BM. Additives were added by replacing corn.
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Biscuit meal was obtained by grinding by-products from the bakery industry such as bread, biscuits, breakfast cereals, cakes, crisps, and snacks. sage. All feed and fecal samples were stored at −20°C until analysis. Before chemical analysis, fecal samples were thawed at 57°C for 72 h, after which they were ground to pass through a 1-mm screen. All feed and fecal samples were analyzed for DM (method 930.15, AOAC, 1995) and CP (method 990.03, AOAC, 1995) . Chromium was analyzed via UV absorption spectrophotometry (Shimadzu UV-1201, Shimadzu, Kyoto, Japan). The ATTD was then calculated using the following formula:
where Nf = nutrient concentration in diet (% DM), Nd = nutrient concentration in diet (% DM), Cd = chromium concentration in feces (% DM), and Cf = chromium concentration in feces (% DM).
On d 14, blood samples were collected from the cervical vein into both vacuum tubes containing K 3 EDTA and nonheparinized vacuum tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ) from 2 pigs (1 gilt and 1 barrow) in each pen, and the same pigs were sampled again on the final day of the experiment. After collection, the serum samples from nonheparinized vacuum tubes were centrifuged (2,000 × g) for 30 min at 4°C. Serum IgG was determined using an automatic biochemistry analyzer (Hitachi 747, Hitachi, Tokyo, Japan). The whole blood samples were analyzed for white blood cells (WBC), red blood cells (RBC), and lymphocyte counts using an automatic blood analyzer (ADVIA 120, Bayer, Tarrytown, NY).
Subjective diarrhea scores were recorded daily from d 10 to 17 by the same person and were based on the following: 1 = well-formed feces, 2 = sloppy feces, 3 = diarrhea (Marquardt et al., 1999) . Scores were recorded on a pen basis following observations of individual pig and signs of stool consistency in the pen. The score is reported as average daily diarrhea of individual pig score.
Statistical Analysis
All experimental data were analyzed using the GLM Procedure as a randomized complete block design (SAS Inst. Inc., Cary, NC). The pen was used as the experimental unit. The initial BW was used as a covariate for ADFI and ADG, and initial values were used as a covariate for blood profile. Differences among treatment means were determined using the Tukey's range test. A probability level of P ≤ 0.05 was considered significant, whereas P < 0.10 was considered a tendency.
RESULTS

Growth Performance
From d 0 to 14, ADG of pigs fed the PC, MO, and FM diets was greater (P < 0.05) than pigs fed the NC diet (Table 3) . Moreover, ADFI of pigs fed the PC, MO, and FM diets was also greater (P < 0.05) than pigs fed the NC diet. From d 15 to 28, there were no differences in ADG, ADFI, and G:F. During the overall period (d 0 to 28), pigs fed the MO diet had a greater ADG than pigs fed the NC diet (P < 0.05). Pigs fed the PC and MO diets had increased ADFI (P < 0.05) compared with pigs fed the NC diet. However, no differences were observed among dietary treatments in G:F during the overall period.
DM and N Digestibility
On d 14, the ATTD of DM for pigs fed the PC, MO, and FM diets was greater (P < 0.05) than pigs fed the NC diet (Table 4 ). The ATTD of DM increased (P < 0.05) in pigs fed the MO and FM diets compared with pigs fed the FC diet. Pigs fed the PC, MO, and FM diets also had greater (P < 0.05) ATTD of N than pigs fed the NC diet. However, at the end of the experiment, pigs fed the FM diet had a greater (P < 0.05) ATTD of DM compared with pigs fed the NC diet.
Blood Profile and Diarrhea Score
Lymphocyte counts, RBC, WBC, and IgG were not affected by dietary treatments on d 0, 14, or 28 (Table  5 ). There were no differences in diarrhea score among the PC, FC, and FM treatments. However, diarrhea score in pigs fed the MO diet was decreased (P < 0.05) compared with pigs fed the NC diet.
DISCUSSION
Previous studies have reported that mannan oligosaccharides supplementation during the nursery phase improved the growth performance of pigs (Dvorak and Jacques, 1998) . Davis et al. (2000 Davis et al. ( , 2002 and Miguel et al. (2003) reported that mannan oligosaccharides improved the growth performance of weanling pigs, and Davis et al. (2000 Davis et al. ( , 2002 observed increases in ADG (4.15%), ADFI (2.08%), and G:F (2.34%) across experiments. In our study, mannan oligosaccharides supplementation increased ADG and ADFI during phase 1 and the overall experimental period, but exerted no effects during phase 2. These results are generally consistent with those of Miguel et al. (2002) , who report- ed that the efficacy of mannan oligosaccharides as a growth promoter has been demonstrated in the early stages of the nursery period.
The processing involved in producing mannan oligosaccharides may change the physical structure of the cell wall in ways that change its effects, and different sources of mannan oligosaccharides may also have different effects on growth performance. White et al. (2002) investigated the use of brewers dried yeast as a source of mannan oligosaccharides in the diets provided to young pigs. The results indicated that growth performance was not enhanced by supplementing the basal diet with brewers dried yeast. Pigs fed the yeast-containing diets consumed less feed, resulting in reduced rates of growth over the 28-d test period.
These different results of mannan oligosaccharides on growth performance in weanling pigs may be caused by inclusion of mannan oligosaccharides from different sources and manufacturers in the diet, as well as differences in the strains, crossbreds, ages, and sexes of weanling pigs, the plane of nutrition, nutrient composition of the diet, gastrointestinal tract microbial population, or other environmental conditions.
In the present study, no effects of β-(2,6)-linked fructan were detected for growth performance of pigs during phase 2 or the overall period, but a tendency toward an increase was noted. No information is currently available on the influence of β-(2,6)-linked fructan in diets fed to pigs, and thus no comparisons could be made with other studies. However, there have been some studies regarding its partial hydrolysate, fructooligosaccharides. In an experiment with fructo-oligosaccharides, an increase in villus height and crypt depth ratio in the distal small intestine was observed in pigs. The increased villus height and crypt depth ratio is favorable for nutrient absorption, and the increased absorptive capacity of the intestinal tract results in improved feed efficiency and faster growth (Shim, 2005) . Additionally, several studies have reported that fructooligosaccharides have beneficial effects on young pigs, improving their growth performance and intestinal health (Houdijk, 1998; Oli et al., 1998; Shim et al., Within a row, means without a common superscript differ (P < 0.05). Within a row, means without a common superscript differ (P < 0.05). 2005). Estrada et al. (2001) reported that during wk 1, ADG was greater and G:F was improved in earlyweaned pigs fed 0.5% fructo-oligosaccharides relative to the control. However, other studies in pigs have reported no effects of fructo-oligosaccharide supplementation on growth performance and intestinal or fecal bacteria populations (Farnworth et al., 1992; Kornegay et al., 1992; Mikkelsen et al., 2003) . Mountzouris et al. (2006) showed that the dietary treatment with 10 g/kg of fructo-oligosaccharides did not influence the populations of the beneficial bacterial, such as Lactobacillus and Bifidobacterium. Taken together, the influence of fructo-oligosaccharides on growth performance in pigs remains unclear; it may depend on pig growth phase, fructo-oligosaccharide dose, or some other factor. Thus, further research is clearly warranted.
In our study, the ATTD of DM and N increased gradually in pigs fed the MO diets. This indicated that mannan oligosaccharides improved nutrient digestibility in weanling pigs and were beneficial to the gastrointestinal tract. Similar results were also reported in previous studies. Collett (2004) noted that mannan oligosaccharides could be used to sustain the gastrointestinal tract environment as well as to modulate the microflora inhabiting the gut, along with the elimination of enteropathogenic bacteria. Miguel et al. (2006) concluded that mannan oligosaccharides are generally derived from the yeast cell wall. The possible beneficial mode of action may be attributable to alterations of intestinal microflora, with associated modifications of immune responses (Newman and Newman, 2001; Davis et al., 2004a,b; Nochta et al., 2009 ) and improvements in the morphology of the small intestine (Savage et al., 1996) . Additionally, several studies in which mannan oligosaccharides were added to animal diets have shown improvements in intestinal morphology (Moran, 2004) such as lengthened villi, which are associated with superior gut health and improved nutrient absorption (Sims et al., 2004) .
Weanling pigs fed β-(2,6)-linked fructan-supplemented diets experienced no increases in the ATTD of DM and N in our research. Because there have been no reports regarding the effects of β-(2,6)-linked fructan on nutrient digestibility in animals, we can only compare our results with those reported in studies of fructo-oligosaccharides or other oligosaccharides. Houdijk (1998) and Mountzouris et al. (2006) demonstrated that fructo-oligosaccharides did not affect nutrient digestibility in growing pigs at the level of 6.8 or 13.5 g/kg and 10 g/kg. Swanson et al. (2002) also reported that the supplementation of fructo-oligosaccharides (1 g/kg) did not affect ileal nutrient digestibilities and total tract macronutrient digestibilities in dogs. Another study conducted by Propst et al. (2003) demonstrated that the dietary supplementation of inulin or oligofructose (3 to 9 g/kg) did not affect nutrient intake or ileal digestibility in dogs. As has been previously demonstrated, β-(2,1)-linked inulin and fructo-oligosaccharides seem to have no substantial positive effect on nutrient digestibility.
The European ban and limitations on the use of several antibiotics were followed by increased piglet mortalities as well as the increased incidence of diarrhea in young piglets (Spring, 1999) . Postweaning diarrhea is one of the principal problems faced by the pig industry. In commercial practice, the use of different additives Within a row, means without a common superscript differ (P < 0.05). Diarrhea score: 1 to 3, where 1 = well-formed feces, 2 = sloppy feces, and 3 = diarrhea.
has been recommended as a way to help reduce diarrhea in piglets, and mannan oligosaccharides have been shown to have positive effects on pig health. Grela et al. (2006) also reported that mannan oligosaccharide supplements may prove beneficial in piglet growth because they reduce diarrhea. In our study, a mannan oligosaccharide-supplemented diet reduced diarrhea score; this was consistent with the results of other studies. The reasons for this function may be that the inhibition of the bacteria responsible for toxin production could prevent or reduce diarrhea severity (Giannella et al., 1983) . Salit and Gotschlich (1977) demonstrated that yeast mannan is a good inhibitor of Escherichia coli binding. This means that yeast mannan may be beneficial in weanling pigs because it prevents E. coli from binding to the gut wall and causing damage.
The administration of fructo-oligosaccharides (Kornegay et al., 1992; Oli et al., 1998) decreases the incidence of diarrhea in pigs and reduces E. coli-induced diarrhea and death in young piglets (Bunce et al., 1995) . These results demonstrate that fructo-oligosaccharides may play a role in combating the postweaning diarrhea caused by enterotoxigenic strains of E. coli. In this study, fructan-supplemented diets did not affect diarrhea score, but tended to reduce diarrhea score.
